Reporting Season - 23 August
Companies covered: Inghams Group (ING), Telix Pharmaceutical (TLX), Accent Group (AX1)
Stocks discussed:
- Inghams Group (ING): FY profit jumps as revenue climbs 7% but warns of challenging conditions ahead as consumers feel the pinch of cost-of-living pressures
- Telix Pharmaceuticals (TLX): HY net profit of $29.7 million, from a net loss last year, with revenue up 65% and reaffirms FY 2024 guidance
- Accent Group (AX1): 33% net loss in net profit after tax, sales rise but reiterates a challenging consumer environment, with a final fully franked dividend of $0.13/share